Skip to main content
. 2021 Apr 12;8:605160. doi: 10.3389/fmed.2021.605160

Table 3.

Influence of recipient's factors on BCVA improvement, CCT variation, and ECD loss observed after surgery, measured at last follow-up (mean: 8.58 ± 4.09 months, from 1 to 12 months).

Mean BCVA improvement p-value % of CCT loss p-value % of ECD loss p-value
Overall cohort 0.68 ± 0.59 <0.001 1.7 ± 7.1 0.087 24.0 ± 11.7 <0.001
Fuchs dystrophy 0.47 ± 0.46 <0.001 2.3 ± 5.8 0.477 24.4 ± 12.2 0.830
Bullous keratopathy 0.89 ± 0.64 0.9 ± 8.5 23.6 ± 11.3
Diabetes mellitus 0.87 ± 0.65 0.142 3.7 ± 8.4 0.156 25.6 ± 13.3 0.479
Systemic hypertension 0.74 ± 0.62 0.160 1.3 ± 7.9 0.602 24.3 ± 12.5 0.697
Glaucoma 0.46 ± 0.67 0.265 4.0 ± 11.4 0.390 23.8 ± 15.2 0.998
Diabetic retinopathy 0.64 ± 0.55 0.736 2.1 ± 8.1 0.898 0.19 ± 11.4 0.339
DSAEK 0.87 ± 0.64 <0.001 0.8 ± 8.5 0.477 23.5 ± 11.2 0.615
Triple procedure 0.49 ± 0.46 2.3 ± 5.7 24.5 ± 12.3
Overall complications 0.78 ± 0.60 0.160 2.0 ± 8.4 0.583 25.2 ± 12.9 0.425
Elevation of IOP 0.80 ± 0.59 0.342 0.7 ± 8.3 0.491 25.6 ± 13.3 0.407
Rebubbling 0.61 ± 0.59 0.485 0.6 ± 7.7 0.485 23.7 ± 14.1 0.867

DSAEK, Descemet stripping automated endothelial keratoplasty; LT, lenticule thickness; DPT, death to preservation time; PT, preservation time; IOP, intraocular pressure.